CMS

CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs
Biopharma Dive
Wed, 06/26/19 - 11:49 pm
hepatitis C
Medicaid
Netflix model
Louisiana
Gilead Sciences
CMS
Federal Court Punts Regarding Remedy Related to CMS’ Invalidated Rule Concerning Medicare Hospital Outpatient Payment Rates for 340B Drugs
FDA Law Blog
Fri, 05/17/19 - 07:16 pm
FDA
CMS
Medicare
340B
CMS reopens coverage determination on next-gen sequencing for cancer patients
Medtech Dive
Tue, 04/30/19 - 09:43 pm
CMS
Medicare
next generation sequencing
cancer
How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life
Motley Fool
Sat, 04/27/19 - 10:47 am
Gilead Sciences
Novartis
CMS
Medicare
CAR-T
Medicare proposes raising CAR-T pay, but reimbursement solution years away
Biopharma Dive
Wed, 04/24/19 - 03:58 pm
CMS
CAR-T
Medicare
reimbursement
CMS demo could pave the path to eliminating Part D rebates
BioCentury
Mon, 04/8/19 - 11:18 pm
CMS
drug pricing
Medicare Part D
drug rebates
Electronic Health Records: A Promising New Way To Fight the Opioid Epidemic
Forbes
Fri, 03/15/19 - 08:37 pm
opioids
opioid crisis
EHRs
EMRs
CMS
Drug spending could rise 6.1 percent annually by 2020, federal projections show
Stat
Wed, 02/20/19 - 08:01 pm
drug spending
CMS
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Fri, 02/15/19 - 12:22 pm
Medicare
CAR-T
cell therapy
CMS
Novartis
Kymriah
Gilead Sciences
Yescarta
Governor moves to boost California's drug price bargaining power
BioCentury
Tue, 01/8/19 - 07:11 pm
drug pricing
CMS
Medicaid
California
CMS rule cuts reimbursement for new Part B drugs
BioCentury
Fri, 11/2/18 - 08:02 pm
Medicare Part B
CMS
reimbursement
physician-administered drugs
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
Mon, 10/15/18 - 11:30 pm
CMS
UnitedHealthcare
Medicare
JNJ
Remicade
biosimilars
Pfizer
Merck
Medtech reporting would change under new opioid law
Mass Device
Wed, 10/10/18 - 09:02 pm
opioids
opioid crisis
Medicare
Medicaid
CMS
devices
Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs
Forbes
Wed, 10/10/18 - 10:27 am
off-label
oncology
oncologists
cancer
CMS
Medicare Part D to allow indication-driven formularies
BioCentury
Thu, 08/30/18 - 08:39 pm
Medicare
Medicare Part D
CMS
formulary
No, Massachusetts, you can't run a PBM-style Medicaid formulary, feds say
Fierce Pharma
Tue, 07/3/18 - 12:08 pm
drug pricing
Massachusetts
Medicaid
CMS
PBMs
Pharma, payers clash over CMS Part D drug rebate plan
HealthcareDive
Sat, 01/20/18 - 02:59 pm
payers
CMS
Medicare Part D
Medicare
drug rebates
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
RAPS.org
Mon, 10/2/17 - 11:18 am
AbbVie
Amgen
Humira
biosimilars
Medicare
Medicaid
CMS
Why regional reimbursement strategies could be right for medtech
Medical Design and Outsourcing
Thu, 03/30/17 - 06:23 pm
devices
reimbursement
CMS
Health Spending Projections By CMS Could Influence AHCA Votes
Forbes
Tue, 03/21/17 - 09:57 am
healthcare reform
CMS
American Health Care Act

Pages